-
Conflicts of interest reported for FDA panel that signed off on Yaz birth control drug
Wednesday, January 11, 2012 � by jg
Washington Monthly blog: An investigation by journalists found some members of a U.S. Food and Drug Administration committee of medical experts that looked into the potential dangers of the Bayer birth control pills Yaz and Yasmin had potential conflicts of interest.
-
Yaz contraceptive continues to generate lawsuits
Monday, July 11, 2011 � by jg
Newark (N.J.) Star-Ledger: Bayer Healthcare allegedly did not provide adequate warnings about the health risks associated with the oral contraceptive, which has been lamed for causing blood clots, heart attacks and strokes.
-
Drugmaker agrees to pay more than $1 billion in Paxil settlements
Wednesday, July 28, 2010 � by jg
Bloomberg BusinessWeek: GlaxoSmithKline’s latest agreement involves more than 800 birth defect cases and brings the total it has agreed to pay in Paxil-related settlements to more than $2 billion.
-
A (small) victory for medical patients, and ethics
Thursday, June 24, 2010 � by scott
The University of Michigan Medical School has decided that it will no longer accept cash from drug companies to underwrite courses designed to keep doctors’ medical licenses current.
-
Maker of Paxil agrees to settle suits brought over birth defects
Wednesday, June 23, 2010 � by jg
The Legal Intelligencer: GlaxoSmithKline “has agreed to settle almost 200 cases in which plaintiffs allege the use of the antidepressant caused birth defects.”
-
Appeal of Prempro verdict denied by U.S. Supreme Court
Monday, June 21, 2010 � by jg
Bloomberg BusinessWeek: An Arkansas jury’s $2.7 million award to a woman who claimed her use of the hormone replacement drug led her to develop breast cancer was allowed to stand.
-
California’s Tort Wars: Election Day by the numbers
Friday, June 11, 2010 � by eric
Tort-war front groups for big oil, insurance and tobacco get walloped on election day.